Breast cancer treatment in India represents a significant financial burden for families, with costs ranging from ₹90,000 to ₹4,00,000 depending on stage and treatment modalities, yet strategic planning can reduce these expenses by 60-85% without compromising quality of care. TL;DR A network of Indian cancer hospitals achieved up to 85% discounts on critical breast cancer drugs through bulk purchasing, reducing treatment cycle costs from $650 to approximately $217 [3] Out-of-p